Evolving Procedures and Therapies
Jun 07, 2017
Oncology care is becoming increasingly relevant for healthcare organizations and professionals. Overall cancer rates are increasing due to rising life expectancy and growing populations. In 2030, more than 21 million men and women worldwide could develop cancer – 50% more than in 2012.1 Because of the exponential growth in the number of patients and the related costs, it’s key to identify advances tailored to improve care and patient outcomes.
This dossier shows, among other things, the transformation of surgery using advanced image guidance and hybrid ORs and offers an outlook for future cancer care. Drug, interventional, and surgical treatment methods are constantly in flux. The care of cancer patients may become more and more individualized, but it will also become more interdisciplinary and increasingly less invasive.
Integration of Diagnosis and Therapy
Genomic data, versatile imaging systems, and hybrid operating rooms: In the future, treatment could be more customized, interdisciplinary, and less invasive than ever before.
Lung Cancer Gets a Sharper Look in the Hybrid OR
With sophisticated image guidance, surgeons at the Methodist Hospital in Houston in the U.S. perform minimally invasive and highly precise interventions on patients’ lungs.
Performing Art in Interventional Oncology Therapy
For Sylvester Comprehensive Cancer Center at the University of Miami imaging has the key role in oncology. New imaging technologies allow them to provide more accurate diagnosis and less invasive therapies.
Quality of Life and More Certainty for Breast Cancer Patients
An Argentinian hospital is successfully trying out a blood test for the protein HER-2/neu biomarker. It may help to determine, at a very early stage, whether a treatment is working.
Shaping the Hybrid Future
Professor Marescaux has revolutionized surgery. In this interview, he talks about hybrid ORs and the importance of augmented reality in surgery for improving patient care in the future.
1International Agency for Research on Cancer, Globocan 2012: http://globocan.iarc.fr/Pages/burden_sel.aspx (accessed 8 May 2017)
The statements by Siemens’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.